Efficacy and Safety of Continuous Risankizumab Therapy vs Treatment Withdrawal in Patients with Moderate to Severe Plaque Psoriasis: A Phase 3 Randomized Clinical Trial
Andrew Blauvelt, Craig L. Leonardi, Melinda Gooderham, Kim A. Papp, Sandra Philipp, Jashin J. Wu, Atsuyuki Igarashi, Mary Flack, Ziqian Geng, Tianshuang Wu, Anne Camez, David Williams, Richard G. Langley
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Efficacy and Safety of Continuous Risankizumab Therapy vs Treatment Withdrawal in Patients with Moderate to Severe Plaque Psoriasis: A Phase 3 Randomized Clinical Trial'. Together they form a unique fingerprint.